Order Article Reprints
Journal: CancersVolume: 14Number: 1041
Article: Real-World Time on Treatment with First-Line Pembrolizumab Monotherapy for Advanced NSCLC with PD-L1 Expression ≥ 50%: 3-Year Follow-Up Data
- Authors:
- Vamsidhar Velcheti1,*,
- Xiaohan Hu2 and
- Yeran Li2
- et al.
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.